CIK 0001382101 · Non-accelerated filer<br>Smaller reporting company
SUTRO BIOPHARMA, INC.
Sign in to watch- Ticker
- STRO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 452441988
- Phone
- 650-392-8412
- Business address
- 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Former names
- SUTRO BIOPHARMA INC, Fundamental Applied Biology Inc
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Executive Officer gave up 894 shares (to pay taxes)
- 4 Open-market buy CHIEF SCIENTIFIC OFFICER bought 17,000 shares at $0.80 ($13,607)
- 4 Open-market buy CFO bought 19,750 shares at $0.81 ($15,998)
- 4 Open-market buy Chief Executive Officer bought 12,500 shares at $0.80 ($10,011)
- 4 Open-market buy Director bought 50,000 shares at $0.80 ($39,950)
- 4 Open-market buy Chief Admin. Ofcr. & GC bought 12,504 shares at $0.80 ($9,993)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 13,417 shares (to pay taxes)
- 3/A Insider 3/A
- 4 Shares withheld for taxes Chief Business Officer gave up 8,944 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 6,708 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 17 · 335 filings